ArticleEuropean radiology2026
Tumor deposits on MRI in rectal cancer-detection and differentiation from lymph nodes with histopathological correlation.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
Abstract
objectiveTumor deposits (TDs) are a negative prognostic factor in colorectal cancer, independent of lymph node metastasis (LNM). This study aimed to investigate the ability of pre-operative MRI to identify TDs and differentiate them from LNM in rectal cancer. MATERIALS AND
methodsPatients with histopathological N1-N2 rectal cancer with and without TDs who underwent curative-intent primary surgery between 2013 and 2023 were retrospectively included. Three radiologists independently reviewed pre-operative MR images for the presence of TDs and LNM. Histopathology served as the reference standard from which interobserver agreement by Cohen's kappa (κ) was calculated. Unblinded node-to-node comparison of MRI and histopathological images was used to identify sources of discrepancies between the modalities. Post hoc analysis stratified on nodal size (> or ≤ 5 mm) was performed.
resultsEighty-eight patients (50% with TDs on histopathology, 74% male, median age 70 [20-89] years) were included, of whom 27 were excluded due to poor image quality. Agreement between MRI and histopathology (p), both for TD-presence (κ = -0.04) and LNM-presence (κ = 0.16), was low. In the node-by-node comparison, 43 out of 50 pTDs (86%) measured ≤ 5 mm, and 131 of 167 pLNM (78%) measured ≤ 5 mm. In post hoc analysis of smaller (≤ 5 mm) nodules, no pTDs and 3% of pLNM were diagnosed using MRI.
conclusionMRI demonstrated limited ability in detecting and differentiating TDs and LNM in pre-operative low-risk patients. Diagnostic performance was particularly poor for nodules ≤ 5 mm, which constituted 174 out of 217 (80%) pathological nodular structures. KEY POINTS: Questions Tumor deposits and lymph node metastasis are important factors for staging rectal cancer, but the ability of pre-operative MRI to detect and differentiate them remains unclear. Findings In low-risk rectal cancer patients treated with primary surgery, tumor deposits and lymph node metastasis are often small (≤ 5 mm) and not detected by MRI. Clinical relevance MRI has a limited ability to identify and differentiate small (≤ 5 mm) tumor deposits and lymph node metastasis in rectal cancer, which must be considered during pre-operative staging and neoadjuvant treatment planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.